Premium
Tumor‐antigen TA‐4 in the detection of recurrence in cervical squamous cell carcinoma
Author(s) -
Kato Hiroshi,
Tamai Kazunori,
Morioka Hitoshi,
Nagai Michihiro,
Nagaya Toshio,
Torigoe Tadashi
Publication year - 1984
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19841015)54:8<1544::aid-cncr2820540813>3.0.co;2-b
Subject(s) - medicine , radioimmunoassay , basal cell , cervix , antigen , cervical carcinoma , uterine cervix , carcinoma , pathology , cell , oncology , cervical cancer , cancer , immunology , biology , genetics
A radioimmunoassay for a tumor‐antigen (TA‐4) of squamous cell carcinoma was used to detect the recurrence in patients with squamous cell carcinoma of the uterine cervix. Of 17 patients who had recurrence, 15 cases showed reappearance of serum TA‐4 levels. Reappearance of serum TA‐4 was faster than other clinical signs of recurrence in 11 cases. These results indicated that TA‐4 assay would be a useful aid for the detection of recurrence in cervical squamous cell carcinoma.